MRNA Oct 2024 85.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 11:37AM EDT
Loading interactive chart…
- Yahoo Finance
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
- Investor's Business Daily
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Moderna stock toppled Friday after the FDA delayed an approval decision on its RSV vaccine until the end of the month.
- Barrons.com
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
The agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or quality.
© 2024 Yahoo. All rights reserved.